Skip to main content

AHA: Lung Inflation Occurs Infrequently With Ventilation During 30:2 CPR

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 17, 2023.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 17, 2023 -- Lung inflation occurs infrequently with bag-valve-mask ventilation during 30:2 cardiopulmonary resuscitation, according to a study published online Nov. 12 in Circulation to coincide with the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.

Ahamed H. Idris, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues studied patients with out-of-hospital cardiac arrest to examine the incidence of lung inflation with bag-valve-mask ventilation while assigned to 30:2 CPR (chest compressions interrupted by ventilation in a ratio of 30:2). A chest compression pause was defined as a 3- to 15-s break in compressions. Ventilation and outcomes were compared in patients with ventilation waveforms in <50 percent of pauses (group 1) and those with waveforms in ≥50 percent of pauses (group 2).

Data were included for 1,976 patients. The researchers found that the mean duration of 30:2 CPR was 9.8 ± 4.9 minutes from the start of chest compressions until advanced airway placement. A total of 26,861 pauses in chest compressions were identified during this period; based on ventilation waveforms, 60 percent of patients were in group 1 (1,177 patients) and 40 percent were in group 2 (799 patients). Per patient, groups 1 and 2 had a median of 12 pauses and two ventilations and 12 pauses and 12 ventilations, respectively. Higher rates of prehospital return of spontaneous circulation, survival to hospital discharge, and survival with favorable neurological outcome were seen in group 2. After adjustment for confounders, these associations persisted.

"Adequate ventilation through bag-valve-mask is a difficult skill to perform properly and must be practiced regularly to maintain proficiency," Idris said in a statement.

Two authors disclosed ties to the biopharmaceutical and medical device industries.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Time-Dependent Probabilities of Favorable Outcomes Examined After CPR

THURSDAY, Feb. 8, 2024 -- For patients with in-hospital cardiac arrest, the time-dependent probabilities of favorable outcomes decrease with duration of cardiopulmonary...

Higher Survival Rates Seen for Overdose-Attributable Cardiac Arrest

MONDAY, Feb. 5, 2024 -- For patients presenting with nonshockable rhythm, those with overdose-attributable out-of-hospital cardiac arrest (OD-OHCA) have higher survival rates with...

Lasting Benefits Seen for Cardiac Resynchronization Therapy With Defibrillator

THURSDAY, Jan. 18, 2024 -- Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.